Skip to main content
SpringerLink
Log in

Assessment of Quality of Life and Benefits from Adjuvant Therapies in Breast Cancer

  • Conference paper
Adjuvant Therapy of Breast Cancer IV

Part of the book series: Recent Results in Cancer Research ((RECENTCANCER,volume 127))

Abstract

The traditional outcome parameters employed in clinical research in oncology include tumor response, local recurrence rate, development of metastatic disease, disease-free and overall survival, and, in the case of palliative therapies, the control of major physical symptoms. Increasingly, however, there is interest in incorporating a broader set of evaluation criteria that reflect the impact of the disease and of its treatment on the functional, psychological, and social health of the individual patient.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Aaronson NK, Bullinger M, Ahmedzai S (1988) A modular approach to quality of life assessment in cancer clinical trials. Recent Results Cancer Res 111: 231–249

    PubMed  CAS  Google Scholar 

  2. Aaronson NK, Bullinger M, Ahmedzai S et al. (1991) The EORTC core quality- of-life questionnaire: interim results of an international field study. In: Osoba D (ed) Effect of cancer on quality of life. CRC, London, pp 185–203

    Google Scholar 

  3. Berglund G, Bolund C, Fornander T, Rutqvist LE, Sjödén P (1991) Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients. Eur J Cancer 27:1075–1081

    Article  PubMed  CAS  Google Scholar 

  4. Bergner M, Bobbitt RA, Carter WB, Gilson BS (1981) The sickness impact profile: development and final revision of a health status measure. Med Care 19:787–805

    Article  PubMed  CAS  Google Scholar 

  5. Brunner KW (1989) Adjuvant therapies in breast cancer and quality of life: a critical review of the TWIST concept. Recent Results Cancer Res 115:239–243

    PubMed  CAS  Google Scholar 

  6. Cairns J (1985) The treatment of disease and the war against cancer. Sci Am 253:31–39

    Article  Google Scholar 

  7. Cassileth BR, Knuiman MW, Abeloff MD, Falkson G, Ezdinli EZ, Mehta CR (1986) Anxiety levels in patients randomized to adjuvant therapy versus observation for early breast cancer. J Clin Oncol 4:972–974

    PubMed  CAS  Google Scholar 

  8. Cella DF, Tulsky DS (1990) Measuring quality of life today: methodological aspects. Oncology 4:29–38

    PubMed  CAS  Google Scholar 

  9. Cella DF, Lee-Riordan D, Silberman M et al. (1989) Quality of life in advanced cancer: three new disease-specific measures (Abstr). Proc Am Soc Clin Oncol 8:315

    Google Scholar 

  10. Chambers LW, MacDonald LA, Tugwell P, Buchanan W, Kraag G (1982) The McMaster health index questionnaire as a measure of quality of life for patients with rheumatoid disease. J Rheumatol 9:780–784

    PubMed  CAS  Google Scholar 

  11. De Haes JCJM, van Knippenberg FCE (1985) The quality of life of cancer patients: a review of the literature. Soc Sci Med 20:809–817

    Article  PubMed  Google Scholar 

  12. De Haes JCJM, van Knippenberg FCE, Neijt JP (1990) Measuring psychological and physical distress in cancer patients: structure and application of the Rotterdam symptom checklist. Br J Cancer 62:1034–1038

    Article  PubMed  Google Scholar 

  13. Fayers PM, Jones SDR (1983) Measuring and analyzing the quality of life in cancer clinical trials: a review. Stat Med 2:429–446

    Article  PubMed  CAS  Google Scholar 

  14. Feinstein AR (1987) Clinimetric perspectives. J Chronic Dis 40:635–640

    Article  PubMed  CAS  Google Scholar 

  15. Feldstein ML (1991) Quality-of-life-adjusted survival comparing cancer treatments. Cancer 67:851–854

    Article  PubMed  CAS  Google Scholar 

  16. Ganz PA, Polinsky MI, Schag CAC, Heinrich RL (1989) Rehabilitation of patients with primary breast cancer: assessing the impact of adjuvant therapy. Recent Results Cancer Res 115:244–254

    PubMed  CAS  Google Scholar 

  17. Ganz PA, Coscarelli Schag CA, Cheng HL (1990) Assessing the quality of life - a study in newly diagnosed breast cancer patients. J Clin Epidemiol 43:75–86

    Article  PubMed  CAS  Google Scholar 

  18. Gelber RD, Goldhirsch A (1986) A new endpoint for the assessment of adjuvant therapy in postmenopausal women with operable breast cancer. J Clin Oncol 4:1772–1779

    PubMed  CAS  Google Scholar 

  19. Goldhirsch A, Gelber RD, Simes RJ, Glasziou P, Coates AS (1989) Costs and benefits of adjuvant therapy in breast cancer: a quality-adjust survival analysis. J Clin Oncol 7:36–44

    PubMed  CAS  Google Scholar 

  20. Gough IR, Furnival CM, Schilder L, Grove W (1983) Assessment of the quality of life of patients with advanced cancer. Eur J Cancer Clin Oncol 19:1161–1165

    Article  PubMed  CAS  Google Scholar 

  21. Guyatt G, Feeny D, Patrick D (1991) Issues in quality-of-life measurement in clinical trials. Controlled Clin Trials 12:81S–90S

    Article  PubMed  CAS  Google Scholar 

  22. Hughson AVM, Cooper AF, McArdle CS, Smith DC (1986) Psychological impact of adjuvant chemotherapy in the first two years after mastectomy. Br Med J 293:1268–1271

    Article  CAS  Google Scholar 

  23. Hunt SM, McEwen J (1980) The development of a subjective health indicator. Sociol Health Jll 2:231–246

    Article  CAS  Google Scholar 

  24. Hürny C, Bernhard J, Gelber RD et al. (1992) Quality of life measures for patients receiving adjuvant therapy for breast cancer: an international trial. Eur J Cancer (in press)

    Google Scholar 

  25. Hutchinson TA, Boyd NF, Feinstein AR (1979) Scientific problems in clinical scales as demonstrated by the Kamofsky index of performance status. J Chronic Dis 32:661–666

    Article  PubMed  CAS  Google Scholar 

  26. Irvine D, Brown B, Crooks D, Roberts J, Browne G (1991) Psychosocial adjustment in women with breast cancer. Cancer 67:1097–1117

    Article  PubMed  CAS  Google Scholar 

  27. Johnson JR, Temple R (1985) Food and Drug Administration requirements for approval of new anticancer drugs. Cancer Treat Rep 69:1155–1157

    PubMed  CAS  Google Scholar 

  28. Kaplan RM, Buksh JW (1982) Health-related quality of life measurement for evaluation research and policy analysis. J Healt Econ 5:1–30

    Google Scholar 

  29. Kiebert GM, de Haes JCJM, van de Velde CJH (1991) The impact of breast- conserving treatment and mastectomy on the quality of life of ealry-stage breast cancer patients: a review. J Clin Oncol 9:1059–1070

    PubMed  CAS  Google Scholar 

  30. Knopf T (1990) Symptoms and rehabilitation needs of patients with early stage breast cancer during primary therapy. Cancer 66:1392–1401

    Article  Google Scholar 

  31. Levine MN, Guyatt GH, Gent M et al. (1988) Quality of life in stage II breast cancer: an instrument for clinical trials. J Clin Oncol 6:1798–1810

    PubMed  CAS  Google Scholar 

  32. Love RR, Leventhal H, Easterling DV, Nerenz DR (1989) Side effects and emotional distress during cancer chemotherapy. Cancer 63:604–612

    Article  PubMed  CAS  Google Scholar 

  33. Maguire GP, Tait A, Brooke M, Thomas C (1980) Psychiatric morbidity and physical toxicity associated with adjuvant chemotherapy after mastectomy. Br Med J 281:1179–1180

    Article  PubMed  CAS  Google Scholar 

  34. Mcardle CS, Caiman KC, Cooper AF, Hughson AVM, Russell AR, Smith DC (1981) The social, emotional and financial implications of adjuvant chemotherapy in breast cancer. Br J Surg 68:261–264

    Article  PubMed  CAS  Google Scholar 

  35. Padilla GV, Presant C, Grant MM, Metter G, Lipsett J, Heide F (1983) Quality of life index for patients with Cancer. Res Nurs Health 6:117–126

    Article  PubMed  CAS  Google Scholar 

  36. Palmer BV, Walsh GA, McKinna JA, Greening WP (1980) Adjuvant chemotherapy for breast cancer: side effects and quality of life. Br Med J 281:1594–1597

    Article  PubMed  CAS  Google Scholar 

  37. Schag CC, Heinrich RL, Ganz PA (1984) Karnofsky performance status revisited: reliability, validity and guidelines. J Clin Oncol 2:187–193

    PubMed  CAS  Google Scholar 

  38. Schipper H, Clinch J, McMurray A, Levitt M (1984) Measuring the quality of life of cancer patients: the functional living index-cancer. J Clin Oncol 2:472–483

    PubMed  CAS  Google Scholar 

  39. Selby PJ, Chapman JA, Etazadi-Amoli J, Dailey D, Boyd NF (1984) The development of a method of assessing the quality of life for cancer patients. Br J Cancer 50:13–22

    Article  PubMed  CAS  Google Scholar 

  40. Spitzer WO (1987) State of science 1986: quality of life and functional status as target variables for research. J Chronic Dis 40:473–480

    Article  Google Scholar 

  41. Spitzer WO, Dobson AJ, Hall J, Chesterman E, Levi J, Shepherd R, Battista RN, Catchlove BR (1981) Measuring the quality of life cancer patients: a concise QL-index for use by physicians. J Chronic Dis 34:585–597

    Article  PubMed  CAS  Google Scholar 

  42. Stewart AL, Hays RD, Ware JE (1988) The MOS short-form general health survey: reliability and validity in a patient population. Med Care 26:724–735

    Article  PubMed  CAS  Google Scholar 

  43. Tamburini M, Brambilla C, Ferrari L, Bombino T, Gangeri L, Rosso S (1991) Two simple indexes used to evaluate the impact of therapy on the quality of life of patients receiving primary chemotherapy for operable breast cancer. Ann Oncol 2:417–422

    PubMed  CAS  Google Scholar 

  44. Torrance GW (1986) Measurement of health state utilities for economic appraisal. J Health Econ 5:1–30

    Article  PubMed  CAS  Google Scholar 

  45. van Knippenberg FCE, de Haes JCJM (1988) Measuring the quality of life of cancer patients: psychometric properties of instruments. J Clin Epidemiol 41:1043–1053

    Article  PubMed  Google Scholar 

  46. Ware JE Jr (1984) Conceptualizing disease impact and treatment outcomes. Cancer 53:2216–2326

    Google Scholar 

  47. Ware JE Jr (1987) Standards for validating health measures: definitions and content. J Chronic Dis 40:473–480

    Article  PubMed  Google Scholar 

  48. Ware JE Jr, Sherbourne CD (1992) The MOS 36-item short form health survey (SF-36). I. Conceptual framework and item selection. Med Care (in press)

    Google Scholar 

  49. World Health Organization (1947) The constitution of the World Health Organization. WHO Chronicle 1:2

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Psychosocial Research and Epidemiology, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands

    N. K. Aaronson

Authors
  1. N. K. Aaronson
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine C, Kantonsspital, CH-9007, St. Gallen, Switzerland

    Hans-Jörg Senn  & Beat Thürlimann  & 

  2. Division of Biostatistics, Dana Farber Cancer Institute, 44, Binney Street, Boston, MA, 02115, USA

    Richard D. Gelber Ph.D.

  3. Ospedale Civico, CH-6900, Lugano, Switzerland

    Aron Goldhirsch

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Aaronson, N.K. (1993). Assessment of Quality of Life and Benefits from Adjuvant Therapies in Breast Cancer. In: Senn, HJ., Gelber, R.D., Goldhirsch, A., Thürlimann, B. (eds) Adjuvant Therapy of Breast Cancer IV. Recent Results in Cancer Research, vol 127. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84745-5_28

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-84745-5_28

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-84747-9

  • Online ISBN: 978-3-642-84745-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation